The Oncology Insights Podcast - Dr. Michael Hofman: PSMA Theranostics in Oncology | Ep. 14

In this episode of The Oncology Insights Podcast, Dr. Michael Hofman, nuclear medicine physician and professor at Peter MacCallum Cancer Centre, speaks with Dr. William Oh about the evolution of theranostics and targeted radiopharmaceutical therapy. The discussion covers radioactive iodine, PSMA PET imaging, lutetium 177 therapy, prostate cancer treatment, clinical development, and opportunities to apply targeted radiation across additional cancer types. Listen now on all major platforms!

What you’ll learn: 

• Theranostics in oncology
• Targeted radiation delivery
• PSMA imaging advances
• Prostate cancer therapy
• Future radiopharmaceutical applications

Meet the guest:

Dr. Michael Hofman is a nuclear medicine physician and professor at Peter MacCallum Cancer Centre whose research focuses on PSMA PET imaging, radioligand therapy, and prostate cancer. He has led multicenter clinical trials supporting advances in targeted cancer imaging and treatment, published more than 300 papers, and secured substantial research funding. Listen to Dr. Michael Hofman on The Oncology Insights Podcast, available on all major platforms.

Liked this one? Don’t stop now. Here’s what we think you’ll love!